✦ LIBER ✦

Secondary cytoreductive surgery in recurrent epithelial ovarian cancer

✍ Scribed by M. Morris; D. Gershenson; J.T. Wharton

Book ID: 119053320
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 165 KB
Volume: 32
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(89)90923-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secondary Cytoreductive Surgery for Loca

Secondary Cytoreductive Surgery for Localized Intra-abdominal Recurrences in Epithelial Ovarian Cancer

✍ Adnan Munkarah; Charles Levenback; Judith K. Wolf; Diane Bodurka-Bevers; Guiller 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Secondary cytoreductive surgery in the m

Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer

✍ Jeong-Yeol Park; Jeong-Min Eom; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Youn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Secondary cytoreductive surgery for isol

Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer

✍ Antonio Santillan; Amer K. Karam; Andrew J. Li; Robert Giuntoli II; Ginger J. Ga 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Secondary cytoreductive surgery for isol

Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer

✍ Maurie Markman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Secondary cytoreductive surgery in patie

Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer

✍ Stelios Fotiou; Tserkezoglou Aliki; Zarganis Petros; Stauropoulou Ioanna; Velent 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Surgery in recurrent epithelial ovarian

Surgery in recurrent epithelial ovarian cancer: Benefits on Survival for patients with residual disease of 0.1–1 cm after secondary cytoreduction

✍ Wen-Juan Tian; Rong Jiang; Xi Cheng; Jie Tang; Yan Xing; Rong-Yu Zang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

## Abstract ## Aims Recent retrospective trials stated that a benefit of surgery for recurrent ovarian cancer may be limited to patients in whom a complete cytoreduction (R0) could be achieved. Most of them pointed out there was no difference in survival between residual disease of 0.1–1 cm (R1) a